0000849146-17-000051.txt : 20170224 0000849146-17-000051.hdr.sgml : 20170224 20170224172318 ACCESSION NUMBER: 0000849146-17-000051 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170216 FILED AS OF DATE: 20170224 DATE AS OF CHANGE: 20170224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lifevantage Corp CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841097796 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 9785 S. MONROE STREET STREET 2: SUITE 300 CITY: SANDY STATE: UT ZIP: 84070 BUSINESS PHONE: 801-432-9000 MAIL ADDRESS: STREET 1: 9785 S. MONROE STREET STREET 2: SUITE 300 CITY: SANDY STATE: UT ZIP: 84070 FORMER COMPANY: FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC. DATE OF NAME CHANGE: 20041019 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Washington Beatryx CENTRAL INDEX KEY: 0001698608 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35647 FILM NUMBER: 17638637 MAIL ADDRESS: STREET 1: 9785 S. MONROE STREET, SUITE 300 CITY: SANDY STATE: UT ZIP: 84070 3 1 wf-form3_148797497759169.xml FORM 3 X0206 3 2017-02-16 0 0000849146 Lifevantage Corp LFVN 0001698608 Washington Beatryx 9785 S. MONROE STREET, SUITE 300 SANDY UT 84070 0 1 0 0 Senior VP and General Counsel Common Stock 1383 D Performance Stock Units 2018-12-31 Common Stock 29000.0 D The Performance Stock Units ("PSUs") are subject to a three-year performance period of 1/1/2016 through 12/31/2018, subject to earlier expiration upon a change in control of the issuer ("Performance Period"). Subject generally to the reporting person's continued service with the issuer, each PSU represents a contingent right for such person to receive, within 30 days after the end of the Performance Period, a distribution of common shares of the issuer equal to 0% to 200% of the reported target number of PSUs. The actual number of shares distributed will be based on the issuer's TSR performance during the Performance Period. Vesting for 50% of the target PSUs is based upon the issuer's absolute TSR for the Performance Period as compared to a matrix of fixed numeric values and the vesting for the other 50% of the target PSUs is based upon a relative comparison of the issuer's TSR to the Vanguard Russell 2000 exchange traded fund TSR for such period. /s/ Beatryx Washington 2017-02-24 EX-24 2 beatryxwashingtonpowerofat.htm BEATRYX WASHINGTON POWER OF ATTORNEY

POWER OF ATTORNEY
      Know all by these presents that the undersigned hereby constitutes and appoints Lauren McGee
and Kirt Shuldberg, with full power of substitution, as the undersigned's true and lawful attorneys-in-
fact to:
      (1)    prepare, execute in the undersigned's name and on the undersigned's behalf, and submit
to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments
thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the
undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the
Securities Exchange Act of 1934 or any rule or regulation of the SEC;
      (2)    execute for and on behalf of the undersigned, in the undersigned's capacity as an officer
and/or director of LifeVantage Corporation (the "Company") and/or 10% holder of the Company's
capital stock, Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of
1934 and the rules thereunder;
      (3)    do and perform any and all acts for and on behalf of the undersigned which may be
necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any
amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or
similar authority; and
      (4)    take any other action of any type whatsoever in connection with the foregoing which, in
the opinion of such attorneys-in-fact, may be of benefit to, in the best interest of, or legally required by,
the undersigned, it being understood that the documents executed by such attorneys-in-fact on behalf
of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorneys-in-fact may approve in such attorneys-in-fact's discretion.
      The undersigned hereby grants to each such attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the
exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and
powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any
of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of
1934.
      This Power of Attorney shall remain in full force and effect until the undersigned is no longer
required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed
as of this 16th day of February, 2017.


/s/ Beatryx Washington
Beatryx Washington